Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Voglicaid-M 0.2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Medicaid Labs LLP

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Voglicaid-M 0.2 Tablet SR

Diabetic patients may find relief with the anti-diabetic medication, Voglicaid-M 0.2 SR Tablet. This dual-action formulation is indicated for adult management of type 2 diabetes mellitus, effectively regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage adjustments will be determined by your physician based on your blood sugar monitoring results. Continuous use is crucial, even with controlled blood sugar or feeling well; abrupt cessation, without consulting your doctor, can lead to elevated blood glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating diet, physical activity, and weight management as directed by your physician. Lifestyle choices significantly influence diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes; these are generally transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your doctor can advise on managing these or prescribe alternative treatments. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Furthermore, pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is essential, supplemented by periodic blood tests assessing blood cell counts and liver function as directed by your doctor.

Uses of Voglicaid-M 0.2 Tablet SR

Managing Type 2 diabetes

Major Benefits of Voglicaid-M 0.2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Voglicaid-M 0.2 SR tablets should be administered with a meal.

Common Side effects of Voglicaid-M 0.2 Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Voglicaid-M 0.2 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglicaid-M 0.2mg Extended-Release tablets should be administered with a meal.

How Voglicaid-M 0.2 Tablet SR works:

Voglicaid-M 0.2mg sustained-release tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglicaid-M 0.2 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglicaid-M 0.2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Voglicaid-M 0.2 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

The extended-release Voglicaid-M 0.2mg tablet typically doesn't impair driving ability. Nevertheless, individuals taking it concurrently with other diabetes medications, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Patients with kidney impairment should use Voglicaid-M 0.2 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. Voglicaid-M 0.2 Tablet SR is contraindicated in patients with severe renal disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Voglicaid-M 0.2 Tablet SR use in individuals with hepatic impairment is scarce. Physician consultation is recommended.

What if you forget to take Voglicaid-M 0.2 Tablet SR :

Should you forget a dose of Voglicaid-M 0.2 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglicaid-M 0.2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Voglicaid-M 0.2 Tablet SR
98
MRP 120
18% off